NP0331730 | 3-Hydroxy-4-methoxycinnamic acid | | | C10H10O4
194.1840 Da 194.05791 Da | |
NP0331731 | D-Glucuronic acid lactone | | | C6H8O6
176.1241 Da 176.03209 Da | |
NP0331732 | n-Tricosanoic acid | | | C23H46O2
354.6101 Da 354.34978 Da | |
NP0331733 | n-Tridecanoic acid | | | C13H26O2
214.3443 Da 214.19328 Da | |
NP0331734 | Behenyl Alcohol | | | C22H46O
326.6000 Da 326.35487 Da | |
NP0331735 | n-Undecanoic acid | | | C11H22O2
186.2912 Da 186.16198 Da | |
NP0331736 | phomactinine | | | C20H29NO3
331.4560 Da 331.21474 Da | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) |
|
NP0331737 | 3,5-Dimethoxy-4-hydroxycinnamic Acid | | | C11H12O5
224.2120 Da 224.06847 Da | |
NP0331738 | 3,5 Dimethoxy-4-hydoxyacetophenone | | | C10H12O4
196.1999 Da 196.07356 Da | |
NP0331739 | D-Trehalose | | | C12H22O11
342.2965 Da 342.11621 Da | |
NP0331740 | 2,4 Dihydroxyacetophenone | | | C8H8O3
152.1473 Da 152.04734 Da | |
NP0331741 | 5,7,30 ,40 -tetrahydroxy-6,8-diprenylisoflavone | | | C25H26O6
422.4770 Da 422.17294 Da | |
NP0331742 | Tenaciside P | | | C44H60O14
812.9500 Da 812.39831 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|
NP0331743 | Tenaciside N | | | C47H64O14
853.0150 Da 852.42961 Da | 1H NMR Spectrum (1D, 400, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) |
|
NP0331744 | Tenaciside O | | | C44H62O14
814.9660 Da 814.41396 Da | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
NP0331745 | (3S,8S,9S,10R,11S,12S,13S,14R,17S)-Δ5-3β,8β,14β-trihydroxy-11α-O-tigloyl-12β-O-benzoylpregnane | | | C33H42O8
566.6910 Da 566.28797 Da | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
NP0331746 | 12β-O-tigloyltenacigenin D | | | C26H36O6
444.5680 Da 444.25119 Da | 1H NMR Spectrum (1D, 400, CDCl3, simulated) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) |
|
NP0331747 | Δ5-3β,8β,11α,14α-tetrahydroxy-12β-O-benzoylpregnane | | | C28H36O7
484.5890 Da 484.24610 Da | 1H NMR Spectrum (1D, 400, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) |
|
NP0331748 | (3S,8S,9S,10R,11S,12S,13S,14R,17R,20R)-11α-O-tigloyl-17α-marsectohexol | | | C26H40O7
464.5990 Da 464.27740 Da | 1H NMR Spectrum (1D, 400, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) |
|
NP0331749 | (3S,8S,9S,10R,11S,12S,13S,14R,17R,20R)-11α-O-benzoyl-17α-marsectohexol | | | C28H38O7
486.6050 Da 486.26175 Da | 1H NMR Spectrum (1D, 400, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) |
|
NP0331750 | 12β-O-benzoyltenacigenin D | | | C28H34O6
466.5740 Da 466.23554 Da | 1H NMR Spectrum (1D, 400, CDCl3, simulated) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) |
|
NP0331751 | (3S,5S,8R,9S,10S,12S,13S,14R,17R,20R)-12β-O-phenylacetyltenacigenin A | | | C29H38O6
482.6170 Da 482.26684 Da | 1H NMR Spectrum (1D, 400, CDCl3, simulated) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) |
|
NP0331752 | 12β-O-2-methylbutyryltenacigenin D | | | C26H38O6
446.5840 Da 446.26684 Da | 1H NMR Spectrum (1D, 400, CDCl3, simulated) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) |
|
NP0331753 | 12β-O-4-hydroxyphenylacetyltenacigenin D | | | C29H36O7
496.6000 Da 496.24610 Da | 1H NMR Spectrum (1D, 400, C5D5deposition_typeN, simulated) | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) |
|
NP0331754 | Tenacigenin D | | | C21H30O5
362.4660 Da 362.20932 Da | 1H NMR Spectrum (1D, 400, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) |
|